Hi - I was trying to review the (dated) clinical summary document to see if there was anything that might still be relevant and offer insight into timelines (It would have been helpful if they included talking points in their leaked classified document - c'mon, Follica!). It looks like they are/were trying to do a De Novo on the device and 505(b)(2) with the topical minoxidil. They have the 6 month study (with 200 patients) starting in Q1 of 2017 with De Novo decision in Q3 of 2018 and 505(b)(2) decision in Q4 2018. If those time ranges are still accurate, a realistic best case scenario is mid to late 2023 for release??? Anyone aware of anything that might allow for something earlier?